Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
1,478
archived clinical trials in
Smoking Cessation

Nicotine Lozenge or Tobacco-Free Snuff for Smokeless Tobacco Reduction
A Pilot Study to Compare the Nicotine Lozenge and Tobacco-Free Snuff for Smokeless Tobacco Reduction
Status: Archived
Oregon Research Institute
mi
from
Eugene, OR
Nicotine Lozenge or Tobacco-Free Snuff for Smokeless Tobacco Reduction
A Pilot Study to Compare the Nicotine Lozenge and Tobacco-Free Snuff for Smokeless Tobacco Reduction
Status: Archived
Updated: 1/1/1970
Oregon Research Institute
mi
from
Eugene, OR
Effects of Nicotine on Brain Activity as Measured by fMRI
Effects of Nicotine on Brain Activity as Measured by fMRI
Status: Archived
National Institute on Drug Abuse
mi
from
Baltimore, MD
Effects of Nicotine on Brain Activity as Measured by fMRI
Effects of Nicotine on Brain Activity as Measured by fMRI
Status: Archived
Updated: 1/1/1970
National Institute on Drug Abuse
mi
from
Baltimore, MD
En Pareja: A Latino Couples Intervention to Help Expectant Fathers Quit Smoking
En Pareja: A Latino Couples Intervention to Help Expectant Fathers Quit Smoking
Status: Archived
Duke Univ Med Ctr
mi
from
Durham, NC
En Pareja: A Latino Couples Intervention to Help Expectant Fathers Quit Smoking
En Pareja: A Latino Couples Intervention to Help Expectant Fathers Quit Smoking
Status: Archived
Updated: 1/1/1970
Duke Univ Med Ctr
mi
from
Durham, NC
Nicotine Replacement Therapy (NRT) and Bupropion Mechanisms of Effectiveness in Smokers
NRT & Bupropion Mechanisms of Effectiveness in Smokers: Phase IV Trial
Status: Archived
Southern Ilinois University School of Medicine
mi
from
Springfield, IL
Nicotine Replacement Therapy (NRT) and Bupropion Mechanisms of Effectiveness in Smokers
NRT & Bupropion Mechanisms of Effectiveness in Smokers: Phase IV Trial
Status: Archived
Updated: 1/1/1970
Southern Ilinois University School of Medicine
mi
from
Springfield, IL
Supplemental Nicotine Administration for Smoking Cessation in Posttraumatic Stress Disorder (PTSD)
Supplemental Nicotine Administration for Smoking Cessation in PTSD
Status: Archived
Farnum Center
mi
from
Manchester, NH
Supplemental Nicotine Administration for Smoking Cessation in Posttraumatic Stress Disorder (PTSD)
Supplemental Nicotine Administration for Smoking Cessation in PTSD
Status: Archived
Updated: 1/1/1970
Farnum Center
mi
from
Manchester, NH
Investigation of Cycloserine as a Smoking Cessation Treatment
Cycloserine Enhancement of Extinction Learning
Status: Archived
Veterans Affairs Medical Center - East Orange
mi
from
East Orange, NJ
Investigation of Cycloserine as a Smoking Cessation Treatment
Cycloserine Enhancement of Extinction Learning
Status: Archived
Updated: 1/1/1970
Veterans Affairs Medical Center - East Orange
mi
from
East Orange, NJ
Extended Treatment for Smoking Cessation
Extended Treatment for Smoking Cessation
Status: Archived
Stanford university Hospital and Clinics
mi
from
Stanford, CA
Extended Treatment for Smoking Cessation
Extended Treatment for Smoking Cessation
Status: Archived
Updated: 1/1/1970
Stanford university Hospital and Clinics
mi
from
Stanford, CA
Smoking-Cessation and Stimulant Treatment (S-CAST)
Smoking-Cessation and Stimulant Treatment (S-CAST): Evaluation of the Impact of Concurrent Outpatient Smoking-Cessation and Stimulant Treatment on Stimulant-Dependence Outcomes
Status: Archived
La Frontera
mi
from
Tucson, AZ
Smoking-Cessation and Stimulant Treatment (S-CAST)
Smoking-Cessation and Stimulant Treatment (S-CAST): Evaluation of the Impact of Concurrent Outpatient Smoking-Cessation and Stimulant Treatment on Stimulant-Dependence Outcomes
Status: Archived
Updated: 1/1/1970
La Frontera
mi
from
Tucson, AZ
Smoking-Cessation and Stimulant Treatment (S-CAST)
Smoking-Cessation and Stimulant Treatment (S-CAST): Evaluation of the Impact of Concurrent Outpatient Smoking-Cessation and Stimulant Treatment on Stimulant-Dependence Outcomes
Status: Archived
Matrix Institute on Addicitions
mi
from
Tarzana, CA
Smoking-Cessation and Stimulant Treatment (S-CAST)
Smoking-Cessation and Stimulant Treatment (S-CAST): Evaluation of the Impact of Concurrent Outpatient Smoking-Cessation and Stimulant Treatment on Stimulant-Dependence Outcomes
Status: Archived
Updated: 1/1/1970
Matrix Institute on Addicitions
mi
from
Tarzana, CA
Smoking-Cessation and Stimulant Treatment (S-CAST)
Smoking-Cessation and Stimulant Treatment (S-CAST): Evaluation of the Impact of Concurrent Outpatient Smoking-Cessation and Stimulant Treatment on Stimulant-Dependence Outcomes
Status: Archived
Tarzana Treatment Centers
mi
from
Tarzana, CA
Smoking-Cessation and Stimulant Treatment (S-CAST)
Smoking-Cessation and Stimulant Treatment (S-CAST): Evaluation of the Impact of Concurrent Outpatient Smoking-Cessation and Stimulant Treatment on Stimulant-Dependence Outcomes
Status: Archived
Updated: 1/1/1970
Tarzana Treatment Centers
mi
from
Tarzana, CA
Smoking-Cessation and Stimulant Treatment (S-CAST)
Smoking-Cessation and Stimulant Treatment (S-CAST): Evaluation of the Impact of Concurrent Outpatient Smoking-Cessation and Stimulant Treatment on Stimulant-Dependence Outcomes
Status: Archived
Gateway
mi
from
Jacksonville, FL
Smoking-Cessation and Stimulant Treatment (S-CAST)
Smoking-Cessation and Stimulant Treatment (S-CAST): Evaluation of the Impact of Concurrent Outpatient Smoking-Cessation and Stimulant Treatment on Stimulant-Dependence Outcomes
Status: Archived
Updated: 1/1/1970
Gateway
mi
from
Jacksonville, FL
Smoking-Cessation and Stimulant Treatment (S-CAST)
Smoking-Cessation and Stimulant Treatment (S-CAST): Evaluation of the Impact of Concurrent Outpatient Smoking-Cessation and Stimulant Treatment on Stimulant-Dependence Outcomes
Status: Archived
Gibson Recovery Center, Inc.
mi
from
Cape Girardeau, MO
Smoking-Cessation and Stimulant Treatment (S-CAST)
Smoking-Cessation and Stimulant Treatment (S-CAST): Evaluation of the Impact of Concurrent Outpatient Smoking-Cessation and Stimulant Treatment on Stimulant-Dependence Outcomes
Status: Archived
Updated: 1/1/1970
Gibson Recovery Center, Inc.
mi
from
Cape Girardeau, MO
Smoking-Cessation and Stimulant Treatment (S-CAST)
Smoking-Cessation and Stimulant Treatment (S-CAST): Evaluation of the Impact of Concurrent Outpatient Smoking-Cessation and Stimulant Treatment on Stimulant-Dependence Outcomes
Status: Archived
Maryhaven
mi
from
Columbus, OH
Smoking-Cessation and Stimulant Treatment (S-CAST)
Smoking-Cessation and Stimulant Treatment (S-CAST): Evaluation of the Impact of Concurrent Outpatient Smoking-Cessation and Stimulant Treatment on Stimulant-Dependence Outcomes
Status: Archived
Updated: 1/1/1970
Maryhaven
mi
from
Columbus, OH
Smoking-Cessation and Stimulant Treatment (S-CAST)
Smoking-Cessation and Stimulant Treatment (S-CAST): Evaluation of the Impact of Concurrent Outpatient Smoking-Cessation and Stimulant Treatment on Stimulant-Dependence Outcomes
Status: Archived
ADAPT
mi
from
Roseburg, OR
Smoking-Cessation and Stimulant Treatment (S-CAST)
Smoking-Cessation and Stimulant Treatment (S-CAST): Evaluation of the Impact of Concurrent Outpatient Smoking-Cessation and Stimulant Treatment on Stimulant-Dependence Outcomes
Status: Archived
Updated: 1/1/1970
ADAPT
mi
from
Roseburg, OR
Smoking-Cessation and Stimulant Treatment (S-CAST)
Smoking-Cessation and Stimulant Treatment (S-CAST): Evaluation of the Impact of Concurrent Outpatient Smoking-Cessation and Stimulant Treatment on Stimulant-Dependence Outcomes
Status: Archived
Addiction Medicine Services
mi
from
Pittsburgh, PA
Smoking-Cessation and Stimulant Treatment (S-CAST)
Smoking-Cessation and Stimulant Treatment (S-CAST): Evaluation of the Impact of Concurrent Outpatient Smoking-Cessation and Stimulant Treatment on Stimulant-Dependence Outcomes
Status: Archived
Updated: 1/1/1970
Addiction Medicine Services
mi
from
Pittsburgh, PA
Smoking-Cessation and Stimulant Treatment (S-CAST)
Smoking-Cessation and Stimulant Treatment (S-CAST): Evaluation of the Impact of Concurrent Outpatient Smoking-Cessation and Stimulant Treatment on Stimulant-Dependence Outcomes
Status: Archived
Lexington/Richland Alcohol and Drug Abuse Council
mi
from
Columbia, SC
Smoking-Cessation and Stimulant Treatment (S-CAST)
Smoking-Cessation and Stimulant Treatment (S-CAST): Evaluation of the Impact of Concurrent Outpatient Smoking-Cessation and Stimulant Treatment on Stimulant-Dependence Outcomes
Status: Archived
Updated: 1/1/1970
Lexington/Richland Alcohol and Drug Abuse Council
mi
from
Columbia, SC
Smoking-Cessation and Stimulant Treatment (S-CAST)
Smoking-Cessation and Stimulant Treatment (S-CAST): Evaluation of the Impact of Concurrent Outpatient Smoking-Cessation and Stimulant Treatment on Stimulant-Dependence Outcomes
Status: Archived
Behavioral Health Services of Pickens County
mi
from
Pickens, SC
Smoking-Cessation and Stimulant Treatment (S-CAST)
Smoking-Cessation and Stimulant Treatment (S-CAST): Evaluation of the Impact of Concurrent Outpatient Smoking-Cessation and Stimulant Treatment on Stimulant-Dependence Outcomes
Status: Archived
Updated: 1/1/1970
Behavioral Health Services of Pickens County
mi
from
Pickens, SC
Smoking-Cessation and Stimulant Treatment (S-CAST)
Smoking-Cessation and Stimulant Treatment (S-CAST): Evaluation of the Impact of Concurrent Outpatient Smoking-Cessation and Stimulant Treatment on Stimulant-Dependence Outcomes
Status: Archived
Dorchester
mi
from
Summerville, SC
Smoking-Cessation and Stimulant Treatment (S-CAST)
Smoking-Cessation and Stimulant Treatment (S-CAST): Evaluation of the Impact of Concurrent Outpatient Smoking-Cessation and Stimulant Treatment on Stimulant-Dependence Outcomes
Status: Archived
Updated: 1/1/1970
Dorchester
mi
from
Summerville, SC
Smoking-Cessation and Stimulant Treatment (S-CAST)
Smoking-Cessation and Stimulant Treatment (S-CAST): Evaluation of the Impact of Concurrent Outpatient Smoking-Cessation and Stimulant Treatment on Stimulant-Dependence Outcomes
Status: Archived
Nexus Recovery Center
mi
from
Dallas, TX
Smoking-Cessation and Stimulant Treatment (S-CAST)
Smoking-Cessation and Stimulant Treatment (S-CAST): Evaluation of the Impact of Concurrent Outpatient Smoking-Cessation and Stimulant Treatment on Stimulant-Dependence Outcomes
Status: Archived
Updated: 1/1/1970
Nexus Recovery Center
mi
from
Dallas, TX
Safety And Efficacy Of 12 Weeks Of Varenicline For Smoking Cessation In Smokers With Depression
A Phase 4 12-week, Double-Blind, Placebo-Controlled, Multicenter Study Evaluating The Safety And Efficacy Of Varenicline Tartrate (CP-526,555) 1mg BID For Smoking Cessation In Subjects With Depression
Status: Archived
Collaborative Neuroscience Network, Inc.
mi
from
Long Beach, CA
Safety And Efficacy Of 12 Weeks Of Varenicline For Smoking Cessation In Smokers With Depression
A Phase 4 12-week, Double-Blind, Placebo-Controlled, Multicenter Study Evaluating The Safety And Efficacy Of Varenicline Tartrate (CP-526,555) 1mg BID For Smoking Cessation In Subjects With Depression
Status: Archived
Updated: 1/1/1970
Collaborative Neuroscience Network, Inc.
mi
from
Long Beach, CA
Safety And Efficacy Of 12 Weeks Of Varenicline For Smoking Cessation In Smokers With Depression
A Phase 4 12-week, Double-Blind, Placebo-Controlled, Multicenter Study Evaluating The Safety And Efficacy Of Varenicline Tartrate (CP-526,555) 1mg BID For Smoking Cessation In Subjects With Depression
Status: Archived
California Neuroscience Research Medical Group, Inc
mi
from
Sherman Oaks, CA
Safety And Efficacy Of 12 Weeks Of Varenicline For Smoking Cessation In Smokers With Depression
A Phase 4 12-week, Double-Blind, Placebo-Controlled, Multicenter Study Evaluating The Safety And Efficacy Of Varenicline Tartrate (CP-526,555) 1mg BID For Smoking Cessation In Subjects With Depression
Status: Archived
Updated: 1/1/1970
California Neuroscience Research Medical Group, Inc
mi
from
Sherman Oaks, CA
Safety And Efficacy Of 12 Weeks Of Varenicline For Smoking Cessation In Smokers With Depression
A Phase 4 12-week, Double-Blind, Placebo-Controlled, Multicenter Study Evaluating The Safety And Efficacy Of Varenicline Tartrate (CP-526,555) 1mg BID For Smoking Cessation In Subjects With Depression
Status: Archived
Behavioral Health and Wellness Program, University of Colorado Denver
mi
from
Aurora, CO
Safety And Efficacy Of 12 Weeks Of Varenicline For Smoking Cessation In Smokers With Depression
A Phase 4 12-week, Double-Blind, Placebo-Controlled, Multicenter Study Evaluating The Safety And Efficacy Of Varenicline Tartrate (CP-526,555) 1mg BID For Smoking Cessation In Subjects With Depression
Status: Archived
Updated: 1/1/1970
Behavioral Health and Wellness Program, University of Colorado Denver
mi
from
Aurora, CO
Safety And Efficacy Of 12 Weeks Of Varenicline For Smoking Cessation In Smokers With Depression
A Phase 4 12-week, Double-Blind, Placebo-Controlled, Multicenter Study Evaluating The Safety And Efficacy Of Varenicline Tartrate (CP-526,555) 1mg BID For Smoking Cessation In Subjects With Depression
Status: Archived
Comprehensive Psychiatric Care
mi
from
Norwich, CT
Safety And Efficacy Of 12 Weeks Of Varenicline For Smoking Cessation In Smokers With Depression
A Phase 4 12-week, Double-Blind, Placebo-Controlled, Multicenter Study Evaluating The Safety And Efficacy Of Varenicline Tartrate (CP-526,555) 1mg BID For Smoking Cessation In Subjects With Depression
Status: Archived
Updated: 1/1/1970
Comprehensive Psychiatric Care
mi
from
Norwich, CT
Safety And Efficacy Of 12 Weeks Of Varenicline For Smoking Cessation In Smokers With Depression
A Phase 4 12-week, Double-Blind, Placebo-Controlled, Multicenter Study Evaluating The Safety And Efficacy Of Varenicline Tartrate (CP-526,555) 1mg BID For Smoking Cessation In Subjects With Depression
Status: Archived
Emerald Coast Mood & Memory, PA
mi
from
Fort Walton Beach, FL
Safety And Efficacy Of 12 Weeks Of Varenicline For Smoking Cessation In Smokers With Depression
A Phase 4 12-week, Double-Blind, Placebo-Controlled, Multicenter Study Evaluating The Safety And Efficacy Of Varenicline Tartrate (CP-526,555) 1mg BID For Smoking Cessation In Subjects With Depression
Status: Archived
Updated: 1/1/1970
Emerald Coast Mood & Memory, PA
mi
from
Fort Walton Beach, FL
Safety And Efficacy Of 12 Weeks Of Varenicline For Smoking Cessation In Smokers With Depression
A Phase 4 12-week, Double-Blind, Placebo-Controlled, Multicenter Study Evaluating The Safety And Efficacy Of Varenicline Tartrate (CP-526,555) 1mg BID For Smoking Cessation In Subjects With Depression
Status: Archived
Clinical Neuroscience Solutions Incorporated
mi
from
Jacksonville, FL
Safety And Efficacy Of 12 Weeks Of Varenicline For Smoking Cessation In Smokers With Depression
A Phase 4 12-week, Double-Blind, Placebo-Controlled, Multicenter Study Evaluating The Safety And Efficacy Of Varenicline Tartrate (CP-526,555) 1mg BID For Smoking Cessation In Subjects With Depression
Status: Archived
Updated: 1/1/1970
Clinical Neuroscience Solutions Incorporated
mi
from
Jacksonville, FL
Safety And Efficacy Of 12 Weeks Of Varenicline For Smoking Cessation In Smokers With Depression
A Phase 4 12-week, Double-Blind, Placebo-Controlled, Multicenter Study Evaluating The Safety And Efficacy Of Varenicline Tartrate (CP-526,555) 1mg BID For Smoking Cessation In Subjects With Depression
Status: Archived
Vince and Associates Clinical Research
mi
from
Overland Park, KA
Safety And Efficacy Of 12 Weeks Of Varenicline For Smoking Cessation In Smokers With Depression
A Phase 4 12-week, Double-Blind, Placebo-Controlled, Multicenter Study Evaluating The Safety And Efficacy Of Varenicline Tartrate (CP-526,555) 1mg BID For Smoking Cessation In Subjects With Depression
Status: Archived
Updated: 1/1/1970
Vince and Associates Clinical Research
mi
from
Overland Park, KA
Safety And Efficacy Of 12 Weeks Of Varenicline For Smoking Cessation In Smokers With Depression
A Phase 4 12-week, Double-Blind, Placebo-Controlled, Multicenter Study Evaluating The Safety And Efficacy Of Varenicline Tartrate (CP-526,555) 1mg BID For Smoking Cessation In Subjects With Depression
Status: Archived
Heartland Research Associates, LLC
mi
from
Wichita, KA
Safety And Efficacy Of 12 Weeks Of Varenicline For Smoking Cessation In Smokers With Depression
A Phase 4 12-week, Double-Blind, Placebo-Controlled, Multicenter Study Evaluating The Safety And Efficacy Of Varenicline Tartrate (CP-526,555) 1mg BID For Smoking Cessation In Subjects With Depression
Status: Archived
Updated: 1/1/1970
Heartland Research Associates, LLC
mi
from
Wichita, KA
Safety And Efficacy Of 12 Weeks Of Varenicline For Smoking Cessation In Smokers With Depression
A Phase 4 12-week, Double-Blind, Placebo-Controlled, Multicenter Study Evaluating The Safety And Efficacy Of Varenicline Tartrate (CP-526,555) 1mg BID For Smoking Cessation In Subjects With Depression
Status: Archived
Northcoast Clinical Trials
mi
from
Beachwood, OH
Safety And Efficacy Of 12 Weeks Of Varenicline For Smoking Cessation In Smokers With Depression
A Phase 4 12-week, Double-Blind, Placebo-Controlled, Multicenter Study Evaluating The Safety And Efficacy Of Varenicline Tartrate (CP-526,555) 1mg BID For Smoking Cessation In Subjects With Depression
Status: Archived
Updated: 1/1/1970
Northcoast Clinical Trials
mi
from
Beachwood, OH
Safety And Efficacy Of 12 Weeks Of Varenicline For Smoking Cessation In Smokers With Depression
A Phase 4 12-week, Double-Blind, Placebo-Controlled, Multicenter Study Evaluating The Safety And Efficacy Of Varenicline Tartrate (CP-526,555) 1mg BID For Smoking Cessation In Subjects With Depression
Status: Archived
University of Cincinnati
mi
from
Cincinnati, OH
Safety And Efficacy Of 12 Weeks Of Varenicline For Smoking Cessation In Smokers With Depression
A Phase 4 12-week, Double-Blind, Placebo-Controlled, Multicenter Study Evaluating The Safety And Efficacy Of Varenicline Tartrate (CP-526,555) 1mg BID For Smoking Cessation In Subjects With Depression
Status: Archived
Updated: 1/1/1970
University of Cincinnati
mi
from
Cincinnati, OH
Safety And Efficacy Of 12 Weeks Of Varenicline For Smoking Cessation In Smokers With Depression
A Phase 4 12-week, Double-Blind, Placebo-Controlled, Multicenter Study Evaluating The Safety And Efficacy Of Varenicline Tartrate (CP-526,555) 1mg BID For Smoking Cessation In Subjects With Depression
Status: Archived
CRI Worldwide LLC
mi
from
Philadelphia, PA
Safety And Efficacy Of 12 Weeks Of Varenicline For Smoking Cessation In Smokers With Depression
A Phase 4 12-week, Double-Blind, Placebo-Controlled, Multicenter Study Evaluating The Safety And Efficacy Of Varenicline Tartrate (CP-526,555) 1mg BID For Smoking Cessation In Subjects With Depression
Status: Archived
Updated: 1/1/1970
CRI Worldwide LLC
mi
from
Philadelphia, PA
Safety And Efficacy Of 12 Weeks Of Varenicline For Smoking Cessation In Smokers With Depression
A Phase 4 12-week, Double-Blind, Placebo-Controlled, Multicenter Study Evaluating The Safety And Efficacy Of Varenicline Tartrate (CP-526,555) 1mg BID For Smoking Cessation In Subjects With Depression
Status: Archived
Clinical Trials of Memphis
mi
from
Bartlett, TN
Safety And Efficacy Of 12 Weeks Of Varenicline For Smoking Cessation In Smokers With Depression
A Phase 4 12-week, Double-Blind, Placebo-Controlled, Multicenter Study Evaluating The Safety And Efficacy Of Varenicline Tartrate (CP-526,555) 1mg BID For Smoking Cessation In Subjects With Depression
Status: Archived
Updated: 1/1/1970
Clinical Trials of Memphis
mi
from
Bartlett, TN
Safety And Efficacy Of 12 Weeks Of Varenicline For Smoking Cessation In Smokers With Depression
A Phase 4 12-week, Double-Blind, Placebo-Controlled, Multicenter Study Evaluating The Safety And Efficacy Of Varenicline Tartrate (CP-526,555) 1mg BID For Smoking Cessation In Subjects With Depression
Status: Archived
FutureSearch Trials
mi
from
Dallas, TX
Safety And Efficacy Of 12 Weeks Of Varenicline For Smoking Cessation In Smokers With Depression
A Phase 4 12-week, Double-Blind, Placebo-Controlled, Multicenter Study Evaluating The Safety And Efficacy Of Varenicline Tartrate (CP-526,555) 1mg BID For Smoking Cessation In Subjects With Depression
Status: Archived
Updated: 1/1/1970
FutureSearch Trials
mi
from
Dallas, TX
Safety And Efficacy Of 12 Weeks Of Varenicline For Smoking Cessation In Smokers With Depression
A Phase 4 12-week, Double-Blind, Placebo-Controlled, Multicenter Study Evaluating The Safety And Efficacy Of Varenicline Tartrate (CP-526,555) 1mg BID For Smoking Cessation In Subjects With Depression
Status: Archived
Claghorn-Lesem Research Clinic
mi
from
Houston, TX
Safety And Efficacy Of 12 Weeks Of Varenicline For Smoking Cessation In Smokers With Depression
A Phase 4 12-week, Double-Blind, Placebo-Controlled, Multicenter Study Evaluating The Safety And Efficacy Of Varenicline Tartrate (CP-526,555) 1mg BID For Smoking Cessation In Subjects With Depression
Status: Archived
Updated: 1/1/1970
Claghorn-Lesem Research Clinic
mi
from
Houston, TX
Effectiveness of Pedialink CEASE Module
Evaluating Online Clinical Office-Systems Training to Address SHS Exposure of Children
Status: Archived
Massachusetts General Hospital
mi
from
Boston, MA
Effectiveness of Pedialink CEASE Module
Evaluating Online Clinical Office-Systems Training to Address SHS Exposure of Children
Status: Archived
Updated: 1/1/1970
Massachusetts General Hospital
mi
from
Boston, MA
Cognitive Behavioral Smoking Cessation Intervention for Adults With Chronic Pain
Cognitive Behavioral Smoking Cessation Intervention for Adults With Chronic Pain
Status: Archived
Mayo Clinic College of Medicine
mi
from
Rochester, MN
Cognitive Behavioral Smoking Cessation Intervention for Adults With Chronic Pain
Cognitive Behavioral Smoking Cessation Intervention for Adults With Chronic Pain
Status: Archived
Updated: 1/1/1970
Mayo Clinic College of Medicine
mi
from
Rochester, MN
Tobacco Cessation Treatment for Alaska Native Youth
Tobacco Cessation Treatment for Alaska Native Youth
Status: Archived
Yukon Kuskokwim Health Corporation
mi
from
Bethel, AK
Tobacco Cessation Treatment for Alaska Native Youth
Tobacco Cessation Treatment for Alaska Native Youth
Status: Archived
Updated: 1/1/1970
Yukon Kuskokwim Health Corporation
mi
from
Bethel, AK
Mindfulness Training for Smoking Cessation
Assessing Mindfulness Training as a Mechanistic Probe for Stress-Induced Brain Activation and Relapse Prevention for Tobacco Addiction
Status: Archived
VA Connecticut Healthcare System
mi
from
West Haven, CT
Mindfulness Training for Smoking Cessation
Assessing Mindfulness Training as a Mechanistic Probe for Stress-Induced Brain Activation and Relapse Prevention for Tobacco Addiction
Status: Archived
Updated: 1/1/1970
VA Connecticut Healthcare System
mi
from
West Haven, CT
Dynamic Assessment and Referral System - Evaluation
The Dynamic Assessment and Referral System for Substance Abuse: Evaluation
Status: Archived
Umass Memorial Medical Center
mi
from
Worcester, MA
Dynamic Assessment and Referral System - Evaluation
The Dynamic Assessment and Referral System for Substance Abuse: Evaluation
Status: Archived
Updated: 1/1/1970
Umass Memorial Medical Center
mi
from
Worcester, MA
Tobacco Treatment Outreach to Reduce Disparities for Primary Care Populations
Tobacco Treatment Outreach to Reduce Disparities for Primary Care Populations
Status: Archived
Brigham & Women's Hospital Women's Health Center
mi
from
Chestnut Hill, MA
Tobacco Treatment Outreach to Reduce Disparities for Primary Care Populations
Tobacco Treatment Outreach to Reduce Disparities for Primary Care Populations
Status: Archived
Updated: 1/1/1970
Brigham & Women's Hospital Women's Health Center
mi
from
Chestnut Hill, MA
Developing Genetic Education for Smoking Cessation
Developing Genetic Education for Smoking Cessation
Status: Archived
University of Nebrasaka Medical Center
mi
from
Omaha, NE
Developing Genetic Education for Smoking Cessation
Developing Genetic Education for Smoking Cessation
Status: Archived
Updated: 1/1/1970
University of Nebrasaka Medical Center
mi
from
Omaha, NE
Testing Counseling Styles to Motivate Smokers to Quit
Can Motivational Interviewing be Effective for Smoking Cessation?
Status: Archived
University of Missouri-Kansas City
mi
from
Kansas City, MO
Testing Counseling Styles to Motivate Smokers to Quit
Can Motivational Interviewing be Effective for Smoking Cessation?
Status: Archived
Updated: 1/1/1970
University of Missouri-Kansas City
mi
from
Kansas City, MO
Medications Development for the Treatment of Cannabis Related Disorders
Medications Development for the Treatment of Cannabis Related Disorders
Status: Archived
University of Virginia Health Systems
mi
from
Charlottesville, VA
Medications Development for the Treatment of Cannabis Related Disorders
Medications Development for the Treatment of Cannabis Related Disorders
Status: Archived
Updated: 1/1/1970
University of Virginia Health Systems
mi
from
Charlottesville, VA
Medications Development for the Treatment of Cannabis Related Disorders
Medications Development for the Treatment of Cannabis Related Disorders
Status: Archived
University of Virginia
mi
from
Charlottesville, VA
Medications Development for the Treatment of Cannabis Related Disorders
Medications Development for the Treatment of Cannabis Related Disorders
Status: Archived
Updated: 1/1/1970
University of Virginia
mi
from
Charlottesville, VA
Smoking Abstinence and Lapse Effects in Smokers With Schizophrenia and Controls
Smoking Abstinence and Lapse Effects in Smokers With Schizophrenia and Controls
Status: Archived
Brown Univerity
mi
from
Providence, RI
Smoking Abstinence and Lapse Effects in Smokers With Schizophrenia and Controls
Smoking Abstinence and Lapse Effects in Smokers With Schizophrenia and Controls
Status: Archived
Updated: 1/1/1970
Brown Univerity
mi
from
Providence, RI
To Examine Smoking Behavior of Prisoners - 1
Smoking Research With Incarcerated Females
Status: Enrolling
Updated:  12/31/1969
Virginia Commonwealth University
mi
from
Richmond, VA
To Examine Smoking Behavior of Prisoners - 1
Smoking Research With Incarcerated Females
Status: Enrolling
Updated: 12/31/1969
Virginia Commonwealth University
mi
from
Richmond, VA
Click here to add this to my saved trials
Combined Pharmaco/Behavior Therapy in Adolescent Smokers
Combined Pharmaco/Behavior Therapy in Adolescent Smokers
Status: Enrolling
Updated:  12/31/1969
Medical University of South Carolina
mi
from
Charleston, SC
Combined Pharmaco/Behavior Therapy in Adolescent Smokers
Combined Pharmaco/Behavior Therapy in Adolescent Smokers
Status: Enrolling
Updated: 12/31/1969
Medical University of South Carolina
mi
from
Charleston, SC
Click here to add this to my saved trials
Smoking Cessation for Depressed Smokers
Smoking Cessation Intervention for Depressed Smokers: Treatment Development
Status: Enrolling
Updated:  12/31/1969
University of Texas M.D. Anderson Cancer Center
mi
from
Houston, TX
Smoking Cessation for Depressed Smokers
Smoking Cessation Intervention for Depressed Smokers: Treatment Development
Status: Enrolling
Updated: 12/31/1969
University of Texas M.D. Anderson Cancer Center
mi
from
Houston, TX
Click here to add this to my saved trials
Varenicline Effects In Schizophrenic Smokers
Evaluation of Varenicline's Clinical Efficacy for Continued Smoking Abstinence When Used in the Clinical Treatment of Schizophrenic Patients Hospitalized in an Institution With a Ban on Cigarette Smoking
Status: Enrolling
Updated:  12/31/1969
Manhattan Psychiatric Center
mi
from
New York, NY
Varenicline Effects In Schizophrenic Smokers
Evaluation of Varenicline's Clinical Efficacy for Continued Smoking Abstinence When Used in the Clinical Treatment of Schizophrenic Patients Hospitalized in an Institution With a Ban on Cigarette Smoking
Status: Enrolling
Updated: 12/31/1969
Manhattan Psychiatric Center
mi
from
New York, NY
Click here to add this to my saved trials
Combined Treatment for Tobacco and Alcohol Use in Puerto Rico
Oral Cancer Risk Reduction Through Combined Treatment for Tobacco and Alcohol Use
Status: Enrolling
Updated:  12/31/1969
University of Texas M.D. Anderson Cancer Center
mi
from
Houston, TX
Combined Treatment for Tobacco and Alcohol Use in Puerto Rico
Oral Cancer Risk Reduction Through Combined Treatment for Tobacco and Alcohol Use
Status: Enrolling
Updated: 12/31/1969
University of Texas M.D. Anderson Cancer Center
mi
from
Houston, TX
Click here to add this to my saved trials
Sequential Use of Fluoxetine for Smokers With Elevated Depressive Symptoms
Sequential Use of Fluoxetine for Smokers With Elevated Depressive Symptoms
Status: Enrolling
Updated:  12/31/1969
Butler Hospital
mi
from
Providence, RI
Sequential Use of Fluoxetine for Smokers With Elevated Depressive Symptoms
Sequential Use of Fluoxetine for Smokers With Elevated Depressive Symptoms
Status: Enrolling
Updated: 12/31/1969
Butler Hospital
mi
from
Providence, RI
Click here to add this to my saved trials